We’re thrilled to announce PumasAI’s platinum sponsorship at ICoP India 2026, themed “Quantitative Approaches in Drug Development.” This premier event brings together global leaders in pharmacometrics and clinical development, and PumasAI is proud to be at the forefront, reinforcing our commitment to advancing science-first solutions.

Networking

Date: January 28-31, 2026 | 09:00 – 17:00 IST

Drop by our booth and meet our team of experts, explore cutting-edge tools, and discuss your project needs, explore partnership opportunities, and learn more about our latest advancements. Join us as we share insights, foster collaboration, and continue pushing boundaries in quantitative drug development.

Keynote

Date: January 29, 2026 | 09:15 – 10:00 IST

Speaker: Dr. Amit Roy, Vice President – Scientific & Strategic Consulting

Title: Impact of Model-Informed Drug Development (MIDD) in Oncology

Oncology drug development is notoriously challenging — less than 5% of Phase 1 investigational drugs are ultimately approved. Moreover, the dosage regimens of approved drugs are often sub-optimal — hence the FDA Project Optimus. This talk will discuss some of the major challenges in oncology drug development, and present case studies in which innovative MIDD approaches enabled impactful enhancements of the oncology drug development paradigm.

Session: Young Investigator Session for Pharmacometrics

Date: January 30, 2026 | 15:30 – 16:30 IST

Speaker: Dr. Vijay Ivaturi, Co-Founder & Chief Executive Officer

Poster Presentations

• A Bayesian Population Pharmacokinetic Analysis of Oritavancin in Pediatric Skin Infection Patients | Presenter: Architha Aithal
• Leveraging Model-Informed Bioequivalence and Non-Inferiority Analyses to Waive the Need for a Phase-III Efficacy Study of Hamsyl® in Paediatric Acute Lymphoblastic Leukaemia | Presenter: Tanay Parab
• Switching Patients With Schizophrenia to TV-46000, a Long-Acting Subcutaneous Antipsychotic, From Aripiprazole Once Monthly: Pharmacokinetic-Pharmacodynamic Modeling and Simulation | Presenter: Nikita Ramwani
• A Simulation-Driven Workflow for Conducting Model-Based Bioequivalence (MBBE) Using Pumas | Presenter: Nikita Ramwani
• A workflow for performing Global Sensitivity Analysis (GSA) in Pumas | Presenter: Narasimhan Sriram
• Establishing Bioequivalence of GBL19, a Recombinant Asparaginase Biosimilar, Through PopPK Modeling and Virtual Bioequivalence Analysis | Presenter: Jaya Shree Dilli Batcha
• A Copula Framework for Capturing Multivariate Variability in In Silico Clinical Trials | Presenter: Akshay Tiwari
• Structural Identifiability Workflow in Pumas: Methods and Applications | Presenter: Saugandhika Minnikanti

Post-Conference Workshop

Sign-up for an exclusive deep dive into advanced modeling and simulation techniques, designed to empower the scientific community. Read more here and register now!

Stop by to meet the PumasAI team and explore how our solutions can help power your next stage of growth. We can’t wait to meet you!